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Background—- Previous studies have shown that there is a circadian variation in the incidence of acute myocardial infarction. 
The aim of this study is to examine the circadian rhythms of acute myocardial infarction in patients with type 2 diabetes. 
Methods and Results—1016 consecutive patients admitted to a coronary care unit with acute ST elevation myocardial infarction 
were studied from January 2004 to December 2008. All patients were divided into two groups according to with or without 
diabetes. Admission rates were calculated according to the 6-hour interval of the day (circadian rhythm). The data were 
analyzed for variations within subgroups. In diabetic group, number of patients in the first to fourth quarters was 38, 45, 43, 
46 respectively (NS). The corresponding figures for the controls were 174, 295, 183, 192 (P<0.01). The difference between 
the two groups was significant (P<0.02). 
Conclusion—There is no a significant circadian variation in the onset of acute myocardial infarction in diabetic subjects.
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INTRODUCTION
Circadian variation of the onset of acute myocardial infarction 
(AMI)  has  been  reported  by  some  studies  and  may  carry 
important pathophysiologic implications. Some studies show 
an increased onset in the morning between 6:00 AM and 12:00 
noon. Furthermore, a secondary peak in the late evening has 
also been reported in some studies.1
Diabetes  neuropathy  occurs  in  approximately  16~50% 
of individuals with long-standing type 1 and type 2 diabetes. 
It  may  manifest  as  polyneuropathy,  mononeuropathy2  and/
or  autonomic  neuropathy.  Diabetic  neuropathy  may  lead  to 
loss of the normal circadian pattern of autonomic nervous 
system activity3, and altered normal circadian variation in some 
physiological process.4 Zarich et al report that time of onset 
of ischemia in diabetic patients follows a circadian distribution, 
with a peak incidence in the morning hours, suggesting that 
alterations in sympathovagal balance may have an effect on the 
circadian pattern of cardiovascular events.5 However, there are 
conflicting reports regarding circadian variation on the onset 
of AMI among patients with diabetes. To determine whether 
diabetes has an impact on the circadian variation of AMI onset, 
we  investigate the circadian  pattern  in  diabetic patients and 
compare with the controls.
Design and methods 
Study Population
Consecutive patients admitted to the cardiac care unit (CCU) 
of Xuanwu hospital with ST segment elevation myocardial 
infarction  (STEMI)  between  January  2004  and  December 
2008  were  enrolled.  Inclusion  criteria  were:  age  greater 
than or equal to 18 and diagnosis of STEMI. STEMI was 
diagnosed if two of the following criteria were present: (1) 
the presence of ischemic pain or other symptoms lasting ≥30 
minutes; (2) ST-segment elevation of ≥ 2 mm in at least 2 
contiguous precordial leads, ST-segment elevation of  ≥1mm 
in at least 2 inferior leads (II, III, or aVF), or new left bundle-
branch block; (3) an increase in serum MB isoenzyme of 
creatine kinase(CKMB) to more than twice the upper limit 
of  normal.  Exclusion  criteria:  (1)  myocardial  infarction 
occurring after invasive coronary artery procedures such as 
percutaneous coronary intervention(PCI) or coronary artery 
bypass grafting(CABG ; (2) history of myocardial infarction; 
(3)  causes  of  myocardial  infarction  without  coronary 
atherosclerosis.
All subjects were assigned into two groups according to with 
or without diabetes.
The  diagnosis  of  type  2  diabetes  mellitus  was  based  on 
history of treatment with hypoglycemic agents and/or fasting 
blood glucose >126 mg/dl.
We divided the day in into four 6-h intervals from 0:00 to 
5:59, 6:00 to 11:59, 12:00 to 17:59, and 18:00 to 23:59 and 
calculated number of patients in each interval.
Data collection
For  each  patient  enrolled,  the  structured  data  form  was 
completed by experienced cardiologists within 72 hours after 
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Clinical  features  were  obtained  from  coronary  care  unit 
admission logs and other medical documentation, including: (1) 
baseline data: age, gender, systolic and diastolic blood pressure, 
heart rate, smoking, history of disease (diabetes, hypertension, 
cerebral vascular disease). Duration from onset to emergency 
room was calculated. (2) laboratory examination: white cell count 
(WBC), total cholestrol, peak of MB isoenzyme of creatine 
kinase,  serum  potassium,  blood  glucose,  serum  creatinine 
(CRE).  Fasting  blood  samples  for  laboratory  measurements 
were obtained early in the morning after overnight fasting within 
24h of admission. Left ventricle ejection fraction (LVEF) was 
measured  by  ultrasonic  cardiogram  (UCG)  within  24  hours 
of  admission.  (3)  Clinical  outcome:  Killip  Class,  in-hospital 
mortality.
Statistical analysis
The  hypothesis  that  the  number  of  diabetes  patients  with 
infarction during each time interval was equal to an expected 
frequency was tested using a χ2 goodness of fit analysis. The 
χ2 test was used to assess the significance of circadian variation 
between the two groups.
RESULTS
1. Baseline characteristics
Among 1016 subjects enrolled in this study, 172 were diagnosed 
as diabetes. Compared with the control group, diabetes patients 
were elder and more female. There was no significant difference 
on level of serum creatinine  and left ventricular ejection fraction 
between two groups. Diabetes patients had more comorbidities 
Table 1: Comparison of baseline characteristics of patients 
between two groups
Diabetes group Control group P value
N 172(16.9%) 844(83.1%)
Age(year) 65.3±10.5 62.4±12.4 0.001
Men(%) 105(61.0) 632(74.9) <0.001
Women (%) 67(39.0) 212(25.1) <0.001
Time(h) 5.0 5.0 0.756
Heart rate (bpm) 84.2±20.7 77.9±17.5 <0.001
Systolic pressure(mmHg) 133.6±28.9 132.8±44.6 0.833
Diastolic pressure(mmHg) 80.4±17.0 80.6±16.5 0.419
Killip Class(%) 0.006
 I 82(48.0) 512(62.2)
  II 59(34.5) 225(26.8)
  III 17(9.9) 62(7.4)
  IV 13(7.6) 29(3.5)
WBC(G/L) 10.6±3.8 10.9±5.8 0.801
Peak of CKMB(IU/L) 121.0 144.0 0.041
Cholesterol(mg/dl) 191.4±47.8 186.6±44.7 0.222
Serum creatinine(mg/dl) 1.3±0.5 1.2±0.9 0.123
Serum potassium (mmol/L) 4.3±0.7 4.1±1.5 0.688
Ejection fraction(%) 55.9±11.0 56.0±10.6 0.936
Hypertension(%) 111(64.5%) 367(43.5%) <0.001
Smoker(%) 49(28.5%) 448(53.1%) <0.001
Cerebral vascular disease 39(22.8%) 88(10.6%) 0.001
Death(%) 32(18.6%) 57(6.7%) <0.001
Prior β blocker 29(17.0%) 34(19.6%) 0.06
Data are presented as means±SD, median or cases(percentages) of  patient. WBC, white blood corpuscle; CKMB, 
MB isoenzyme of  creatine kinase
Table 2: distribution of 6-hour interval
       0:00~5:59 6:00~11:59 12:00~17:59 18:00~23:59
diabetes 
group
38(22.2%) 45(26.1%) 43(24.9%) 46(26.8%)
control group 174(20.6%) 295(34.9%) 183(21.7%) 192(22.8%)
Data are presented as case s(percentages) of  patient
and worse in-hospital outcome. Proportion of patients taking 
β adrenergic receptor blockers before onset of MI was similar 
between two groups (table 1).
2. Circadian variation
The 6-h interval of AMI onset was shown in Table 2. There 
was no circadian variation in the incidence of acute myocardial 
infarction  in  diabetic  subjects.  The  circadian  variation  was 
significant  in  the  controls  (P<0.01).  The  peak  incidence 
occurred in the second quarter (6 am to 12 noon), this was 
statistically higher than the average incidence in the remainder 
of  the  day  (P<0.01).  The  difference  between  the  circadian 
pattern of diabetic patients and controls was highly statistically 
significant (P<0.02).
DISCUSSION
Circadian  variation  has  been  demonstrated  in  several  types 
of  acute  cardiovascular  disease,  including  acute  myocardial 
infarction, sudden cardiac death, silent ambulatory ischemia, 
and  thrombotic  stroke.  The  morning  peak  of  incidence  of 
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that a surge in sympathetic activity and vagal withdrawal occurs 
after waking accompanying by increase of plasma levels of 
catecholamine, renin and cortisol (morning peak approximately 
6:00 AM, decreasing but still high until noon). As a result, higher 
level  of  heart  rate,  blood  pressure,  coronary  vascular  tone, 
platelet aggregability and a lower level of fibrinolytic activity 
are observed during the early morning hours. These changes 
may increase shear forces in the coronary arterial bed, thus 
promoting plaque disruption and causing unstable angina and 
AMI. Also, a morning increase in platelet reactivity may make a 
thrombus more likely to grow and cause symptoms.
A study6 including 4,796 patients firstly showed that circadian 
variation of the onset of acute myocardial infarction altered 
with specific clinical characteristics such as diabetes, smoking, 
heart  failure,  non  Q  wave  infarction,  taking  beta-blocking 
drugs. Some study had confirmed this finding,7 but other study 
showed conflicting reports. They failed to demonstrate such 
a  variation  in  the  circadian  pattern  in  the  onset  of  AMI[8] 
among patients with diabetes. Our study showed there was no 
a significant morning peak in patients with diabetes but was 
obvious in control group (6 am to 12 noon).
The  mechanism  of  change  of  circadian  pattern  in  the 
onset of AMI among diabetic subjects is unclear. It can be 
related  to  the  blunting  of  diurnal  variation  in  physiological 
variables. Autonomic nervous system plays an important role 
in determining the circadian pattern of cardiovascular events. 
It suggests that in patients with diabetes, abnormalities in the 
circadian rhythm of autonomic tone may be responsible for 
the altered temporal onset of cardiovascular events.9~12 One 
study,13 found that 25.3% of patients with type 1 diabetes and 
34.3% of patients with type 2 diabetes had abnormal findings 
in more than two of six autonomic function tests. Another 
study observed prevalence rate of autonomic neuropathy for 
individuals with type 1 diabetes was 16.6%.14
As  a  result  of  autonomic  neuropathy,  the  rhythm  of 
sympathovagal balance is significantly attenuated in patients with 
diabetes compared with those without diabetes. The morning 
rise in platelet aggregability has been reported to be lost in 
diabetic patients by some investigators. Plasminogen activator 
inhibitor  1  and  von  Willebrand  factor  show  no  circadian 
variation in patients with diabetes.15 Diabetic subjects also show 
diminished circadian variation in blood pressure.16 Yamamoto 
reported patients with diabetes and symptomatic autonomic 
neuropathy had markedly impaired heart rate variability.17
However, there were also conflicted reports. Behar showed 
the preponderance of the morning peak persisted in patients 
with diabetes mellitus.18 Jamal reported circadian morning peak 
of AMI symptom onset existed in patient with history of type 2 
diabetes less than 5 years, but it was attenuated in patients with 
type 1 diabetes or type 2 diabetes for 5 or more years.19 In this 
study, we demonstrated disappear of morning peak of onset 
of AMI was not associated with duration of diabetes. In fact, 
while  autonomic  dysfunction  is  an  established  complication 
of diabetes and clinical symptoms of autonomic neuropathy 
generally do not occur until long after the onset of diabetes, 
but impaired autonomic function is often detected at the time 
of diabetes diagnosis. Subclinical autonomic dysfunction can, 
however, occur within a year of diagnosis in type 2 diabetes 
patients and within two years in type 1 diabetes patients. This 
suggests that autonomic dysfunction may be present after a 
relatively brief exposure to hyperglycemia or perhaps even in 
the clinically normal range of glucose.20–21 Data in our study 
which  indicates  that  resting  heart  rate  of  diabetic  subjects 
is  higher  than  non  diabetics,  maybe  support  this  opinion 
indirectly, because resting tachycardia is a marker of autonomic 
dysfunction.
The  lack  of  circadian  variation  in  the  onset  of  acute 
myocardial  infarction  may  have  therapeutic  implications.  As 
cardio-protective medication has been shown to exert its effect 
mainly by diminishing the morning peak in acute myocardial 
infarction, the optimal timing of such medication may differ in 
diabetic subjects from their non-diabetic counterparts.22
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